The vaccine development process by Bharat Biotech, Biological E Ltd and Aurobindo Pharma are currently in various stages, while Dr Reddy's and Hetero have tie ups for manufacturing the vaccine

COVID-19 vaccination drive: The mock drill will be like the actual vaccination drive but there will be no vaccine administration. Data will be fed to the Co-WIN app, cold storage will be tested and vaccine transportation from cold storage to the sites, crowd management etc will be checked

Tthe researchers in the Storm Chase study believe a Long-Acting AntiBody (LAAB) known as AZD7442, developed by AstraZeneca, may offer immediate and long-term protection to people who have been recently exposed to coronavirus

The SII CEO says considering the high demand for vaccines in the wake of coronavirus, the next decade could be a \"golden one\" for the entire vaccine industry

From facing a potential collapse to becoming one of the best performing automotive firms in the country, Nikhil Nanda has scripted a remarkable turnaround story at Escorts

The posts for which vacancies are available include those of fire engineers, deputy managers, assistant managers, managers, marketing managers, security analysts, IT security experts among others

DCGI gives a green signal to SII, India will be the first nation to approve the Oxford vaccine under emergency use authorisation; British health regulator is still evaluating Oxford-AstraZeneca data

The Lancet report claimed that the indoor or household air pollution led to 64% fewer deaths in the last two decades (1990-2019) in the country, but outdoor or ambient air pollution, is not only increasing but also killing more people

The goal of COVAX is to deliver two billion doses of safe, effective vaccines that have passed regulatory approval and/or WHO prequalification by the end of 2021

Moderna working with US Centers for Disease Control and Prevention and Operation Warp Speed to prepare distribution of mRNA-1273 if FDA chooses to grant an emergency use authorisation

Alka Sharma, an adviser with the Department of Biotechnology said more than 100 participants from Afghanistan, Bhutan, Maldives, Mauritius, Nepal, Sri Lanka took part in this training programme

US pharmaceutical giant Pfizer began shipping the first batches of its long-awaited and newly-authorised coronavirus vaccine out of a Michigan warehouse on Sunday, setting in motion the biggest vaccination drive in American history

The applications are being examined on scientific basis, using the frameworks that are scientific, frameworks that are globally aligned and ensuring that the vaccine is safe, NITI Aayog member (health) Dr V K Paul said

Landless, marginal, and small farmers together constitute 93.7% of the total agricultural workforce in India. Can sustainable agricultural growth and farmers' well-being be achieved without land reforms?

VK Paul says globally, 33 vaccines are in clinical trial phase, of which 10 vaccines are in advanced trial phase. Key consideration while prioritising population for vaccine inoculation is accessing people with risk to mortality and protection of healthcare system and response system

David Prior says next three months are going to be extremely difficult and the world is pinning hopes on vaccine; Serum Institute also hopes to get approval for emergency use in India soon after nod in the UK

Out of 22,000 volunteers, the company has already recruited around 8,000 volunteers, says Krishna Ella, Chairman and Managing Director of Bharat Biotech

As the country plans to vaccinate 30 crore people by July in the first phase, it may be difficult to bank alone on the Indian vaccines, especially Serum Institute's (SII) Covishield

Chari has been awarded the Defense Meritorious Service Medal, the Meritorious Service Medal, the Aerial Achievement Medal, the Air Force Commendation Medal, the Air Force Achievement Medal, an Iraq Campaign Medal, a Korean Defense Service Medal and the Nuclear Deterrence Operations Service Medal

GSK said phase 1/2 interim results showed an immune response comparable to patients who recovered from COVID-19 in adults aged 18 to 49 years but there was an insufficient response in older adults